ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
32 announcements
HealthCare Global Enterprises held its 28th Annual General Meeting on September 18, 2026, via video conferencing to transact business items listed in the notice.
HealthCare Global Enterprises Limited granted 64,46,843 employee stock options under its ESOS 2026 scheme. The grant carries an exercise price of INR 495 per share.
HealthCare Global Enterprises Limited has dispatched letters to shareholders containing the weblink and path for its FY2025-26 Integrated Annual Report. The 28th AGM is scheduled for September 18, 2026.
HealthCare Global Enterprises Limited announces its 28th Annual General Meeting scheduled for September 18, 2026, via video conferencing to transact the business set forth in the notice.
HealthCare Global Enterprises Limited submitted its Business Responsibility and Sustainability Report for FY 2025-26. The report details the company's ESG initiatives and operational footprint across 48 locations.
HCG reported a strong Q1FY27 with 13% YoY revenue growth and 20% EBITDA growth, driven by volume and improved payor mix.
HCG reported strong Q1 FY27 results with 13% YoY revenue growth and 20% Adjusted EBITDA growth. Strategic focus on oncology and capacity expansion through a new North Bengaluru facility.
HealthCare Global Enterprises reported Q1 FY27 results with revenue of ₹6,951 million, up 13% YoY. The company added 121 operational beds during the quarter.
HealthCare Global Enterprises confirmed no deviation in the utilization of funds raised via its recent Rights Issue for the quarter ended June 30, 2026.
HealthCare Global Enterprises re-appointed M/s. Rao Murthy & Associates as its Cost Auditor for the financial year 2026-27, as approved by the Board.
HealthCare Global Enterprises approved a further investment of up to INR 16 Crore in its wholly-owned subsidiary, HCG Rajkot Hospitals LLP.
Healthcare Global Enterprises Ltd reported revenue from operations of ₹693.4 Cr (+13.3% YoY) and net profit of ₹16.5 Cr (+175.0% YoY) for Q1 FY27.
HCG's subsidiary will acquire a 26% stake in Epic Vighnaharta Renewable Energy for ₹0.38 Crore. This investment enables captive solar power consumption.
HealthCare Global Enterprises has scheduled a board meeting for August 6, 2026, to approve the company's unaudited financial results for the quarter ending June 30, 2026.
HealthCare Global Enterprises announced the approval of its 2026 ESOP scheme via postal ballot. Shareholders also approved director reappointments and remuneration revisions with requisite majorities.
HealthCare Global Enterprises completed the divestment of its subsidiary BACC Health Care. The total consideration for the transaction is ₹37.64 Crore.
Healthcare Global Enterprises initiated a postal ballot for ESOP Scheme 2026 and CEO remuneration revision. The proposed annual compensation for Dr. Manish Mattoo is ₹4 Crore.
HealthCare Global Enterprises issued a postal ballot notice seeking approval for a new ESOP scheme and director reappointments. Shareholders can vote electronically until July 08, 2026.
HCG delivered strong FY26 performance with 15% revenue growth and margin expansion. Strategy focuses on oncology core through the sale of fertility unit Milann and brownfield expansion.
HealthCare Global Enterprises filed its Annual Secretarial Compliance Report for FY 2025-26. The auditor confirmed adherence to SEBI regulations with no adverse observations reported.
HCG delivered strong FY26 results with 15% revenue growth and margin expansion to 18.5%, driven by operational leverage and clinical excellence.
HealthCare Global Enterprises confirmed zero deviation in utilizing ₹424.68 Crore raised through its recent Rights Issue. The funds were deployed for debt repayment and acquisitions.
HealthCare Global reported FY26 revenues of ₹2,545.4 Crore, a 15% year-on-year increase. Adjusted EBITDA grew 19%, reflecting strong oncology network performance and improved capacity utilization.
HCG reported FY26 revenue of INR 25.4bn (up 15% YoY) and Adj. EBITDA of INR 4.7bn (up 19% YoY), driven by network productivity and operational leverage.
HealthCare Global Enterprises appointed Sanjeev Kumar as CFO and re-appointed Rajiv Maliwal as Independent Director. These leadership updates take effect from May 2026.
HealthCare Global Enterprises is divesting its entire stake in BACC Health Care for ₹37.64 Crore. The sale to Inviga Healthcare Fund I enables strategic cancer-care focus.
Healthcare Global Enterprises Ltd reported revenue from operations of ₹650.3 Cr (+11.5% YoY) and net profit of ₹4 Cr (-41.2% YoY) for Q4 FY26.
HealthCare Global approved FY2026 audited results and the ₹37.64 Crore divestment of its BACC subsidiary. The company also appointed a new CFO and Internal Auditor.
HealthCare Global launched a new 132-bed comprehensive cancer hospital in Hebbal, North Bengaluru. The facility introduces Karnataka's first MR-Linac technology for precision oncology.
Healthcare Global Enterprises Limited filed its monitoring agency report for the ₹424.68 Crore rights issue. Proceeds remain unutilized as of the March 2026 quarter end.